Antimicrobial resistance profile of Methicillin Resistant Staphylococcal Aureus from skin and soft tissue isolates

Journal of the Pakistan Medical Association

Volumn 59, Issue 5, 2009, Pages 266-269

  Idrees, Faiza ^a   Jabeen, Kauser ^a   Khan, Muhammad Shoaib ^a   Zafar, Afia ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SKIN INFECTION; SOFT TISSUE INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PAKISTAN; SKIN; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 65949101018     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. John CC, John RS. Therapies and vaccines for emerging bacterial infections: Learning from Methicillin resistant Staphylococcus aureus. Pediatr Clin N Am 2006; 53:699-713. (Pubitemid 44092900)
2. Deresinski S. Methicillin resistant Staphylococcus aureus: An evolutionary, epidemiologic and therapeutic odyssey Clin Infect Dis 2005; 40: 562-573
3. Micek ST. Alternatives to vancomycin for the treatment of methicillin resistant Staphylococcus aureus infections Clin Infect Dis 2007; 45: S184-90.
4. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJC et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections. Clin Infect Dis 2005; 41:1373-1406 (Pubitemid 41581713)
5. Gottlieb T, Mitchell D. The independent evolution of resistance to ciprofloxacin, rifampicin and fusidic acid in methicillin resistant Staphylococcus aureus in Australian teaching hospitals. J Antimicrob Chemother 1998; 42:67-73. (Pubitemid 28356363)
6. O'Neill AJ, Cove HJ, Chopra I. Fusidic acid rifampicin resistance in Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 647-650
7. Koneman EW, Allen SD, Janda WM, Scherckenberger PC, Winn JWC. Color atlas and textbook of diagnostic microbiology. 5th ed. Philadelphia: Lippincott 1997; pp 624-648
8. Clinical Laboratory Standards and Institute. Performance standards for anti microbial susceptibility testing, 10th informational supplement ed. Wayne: Clinical Laboratory Standards, 2006.
9. Mark DK, Blanca JH, Yun FW, Ekaterina VK, Susan MR, Henry MB. Emergence of community acquired methicillin resistant Staphylococcus aureus USA 300 clones as the predominant cause of skin and soft tissue infections. Ann Intern Med 2006; 144: 309-317 (Pubitemid 46768185)
10. Qureshi AH, Rafi S, Qureshi SM, Ali AM. The current susceptibility patterns of MRSA to conventional antistaphylococcal antimicrobials at Rawalpindi. Pak J Med Sci 2004; 20:361-364
11. Hafiz S, Hafiz AN, Ali L, Chughtai AS, Memon B, Ahmed A, et al. Methicillin resistant Staphylococcus aureus: a multicentre study. J Pak Med Assoc 2002; 52: 312-314
12. Anwar MS, Bokhari SR. Antimicrobial resistance of community and hospital acquired Staphylococcal aureus isolates to oxacillin and glycopeptides. J Coll Physicians Surg Pak 2003; 13:33-36 (Pubitemid 36416880)
13. Bashir A, Mujahid TY, Jehan N. Antibiotic resistance profile: isolation and characterization of clinical isolates of staphylococci from patients with community- acquired infections.Pak J Pharm Sci 2007; 20:299-304.
14. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin resistant Staphylococcus aureus in skin and soft tissue infections. Annals of Emergency Medicine 2005; 45:311-320 (Pubitemid 40261163)
15. Shittu AO, Lin J. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infect Dis 2006; 6:125. (Pubitemid 44390025)
16. Howden BP, Grayson ML. Dumb and Dumber. The potential waste of a useful anti-staphylococcal agent: Emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 2006; 42: 394-400.
17. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and Susceptibility of 3,051 Staphylococcus aureus Isolates from 25 University Hospitals participating in the European SENTRY Study. J Clin Microbiol 2001; 39: 3727-3732 (Pubitemid 32954532)
18. Baker CJ, Frenck RW. Change in management of skin/soft tissue infections needed. AAP News 2004; 25; 105.
19. Jorg JR, Thomas M, Robert WB, Anupama M. Tetracycline for MRSA Infections. Clin Infect Dis 2005:40:1429-1434
20. Niks M, Hanzen J, Ohlasová D, Rovná D, Purgelová A, Szövényiová Z, et al. Multiresistant nosocomial bacterial strains and their in vitro susceptibility to chloramphenicol and colistin. Klin Mikrobiol Infekc Lek 2004; 10:124-129
21. Brief Report: Vancomycin-Resistant Staphylococcus aureus - New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53: 322-323
22. Massachusetts Department of Public Health. Infection control guidelines for long-term care facilities: Staphylococcus aureus with resistance to vancomycin (VISA/VRSA). (Online) Aug 2001 (Cited 2007 Jan). Available from URL: http://www.mass.gov/Eeohhs2/docs/dph/cdc/infection-control/visa-vrsa-guide.pdf.
23. Bukhari SZ, Ahmed S. Prevalence of methicillin resistance among Staphylococcus aureus isolates in Pakistan and its clinical outcome. J Hosp Infect 2007; 67:101-102 (Pubitemid 47377732)
24. Butt T, Rifat NA, Usman M, Mahmood A. Methicillin resistant Staphylococcus aureus, Pakistan 1996-2003. Emerg Inf Dis 2004; 9:1691-1692
25. Samia P, Barakzai Q, Farooqi BJ, Nazia K, Sabir N. Antimicrobial susceptibility pattern of clinical isolates of Methicillin Resistant Staphylococcus aureus. J Pak Med Assoc 2007; 57:2-4. (Pubitemid 47202810)